at Biotech Showcase 2013
& J.P. Morgan 31st Annual
January 7-11, 2013
San Francisco, CA, USA
Adding Value to Life Science Investments
Cato BioVentures is the venture capital affiliate of
Cato Research, a global, full-service research and development organization (CRO). For over 20 years, Cato BioVentures and Cato Research have partnered with entrepreneurs, academic institutions, and a broad base of biotech and pharmaceutical companies to advance a robust portfolio of successful product development programs.
If a significant regulatory or clinical event is central to your development plans for 2013 & 2014, then our investment model, coupled with the extensive regulatory and clinical experience track record of Cato Research, can make a positive difference to your organization's success.